Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese”

Showing 20 of 0 results

Not applicableStudy completedNCT00015639
What this trial is testing

Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus

Who this might be right for
Thrombocytopenia
National Institutes of Health Clinical Center (CC) 150
Early research (Phase 1)Study completedNCT00543946
What this trial is testing

Single Ascending Dose of GAP-134 as a 24-hour IV Infusion in Healthy Japanese Males

Who this might be right for
Arrhythmia
Wyeth is now a wholly owned subsidiary of Pfizer 56
Early research (Phase 1)Study completedNCT07456059
What this trial is testing

Evaluate EDG-7500 in Caucasian and Japanese Adults

Who this might be right for
Healthy Adult Participants
Edgewise Therapeutics, Inc. 24
Early research (Phase 1)Study completedNCT01565018
What this trial is testing

Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects

Who this might be right for
Healthy Volunteers
UCB Pharma 55
Early research (Phase 1)Study completedNCT01761526
What this trial is testing

Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects

Who this might be right for
Healthy
UCB BIOSCIENCES GmbH 50
Early research (Phase 1)Study completedNCT05288816
What this trial is testing

Single and Multiple Doses of ALXN1210 in Healthy, Adult Japanese Participants

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 16
Post-approval studies (Phase 4)Study completedNCT03123848
What this trial is testing

Evaluate the Pharmacokinetics (PK) of Darunavir (DRV) and Cobicistat (COBI) After a Single Oral Administration of Darunavir/Cobicistat Fixed-Dose Combination in Healthy Japanese Adult Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 8
Early research (Phase 1)Study completedNCT06368440
What this trial is testing

Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese Participants

Who this might be right for
Healthy Participants
AstraZeneca 39
Early research (Phase 1)Study completedNCT01868555
What this trial is testing

Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 32
Early research (Phase 1)Study completedNCT01595425
What this trial is testing

Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects

Who this might be right for
Bioequivalence Study
AstraZeneca 71
Early research (Phase 1)Looking for participantsNCT06951880
What this trial is testing

Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy Volunteers

Who this might be right for
Healthy Participants
AstraZeneca 160
Early research (Phase 1)Study completedNCT00415883
What this trial is testing

To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers

Who this might be right for
Healthy
Novartis 40
Early research (Phase 1)Study completedNCT01167868
What this trial is testing

Assess the Safety, Tolerability, and Blood and Urine Drug Levels of Fostamatinib Disodium (FosD) in Healthy Japanese and White Subjects

Who this might be right for
Healthy
AstraZeneca 56
Not applicableStudy completedNCT01927250
What this trial is testing

Influence of Multi-dimensional Wellness Program on Quality of Life

Who this might be right for
HealthyPhysical DisordersMental Disorders
MOA Health Science Foundation 12,166
Early research (Phase 1)Study completedNCT00741689
What this trial is testing

Evaluate Safety and Tolerability After Single Oral Dosing of AZD1656 in Japanese Healthy Volunteers

Who this might be right for
Healthy Volunteers
AstraZeneca 36
Early research (Phase 1)Study completedNCT00930215
What this trial is testing

Study Comparing Gelatine Capsule 40 mg D961H and HPMC Capsule in Japanese Healthy Males

Who this might be right for
Healthy
AstraZeneca 48
Early research (Phase 1)Study completedNCT01268124
What this trial is testing

Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects

Who this might be right for
Schizophrenia
Wyeth is now a wholly owned subsidiary of Pfizer 56
Early research (Phase 1)Study completedNCT01100047
What this trial is testing

Japanese Single and Multiple Ascending Dose (JSMAD), Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of AZD5069

Who this might be right for
Healthy
AstraZeneca 63
Early research (Phase 1)Study completedNCT05337878
What this trial is testing

Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pelacarsen (ISIS 681257) in Healthy Japanese Participants

Who this might be right for
Healthy Participants
Ionis Pharmaceuticals, Inc. 29
Early research (Phase 1)Study completedNCT04497883
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Maribavir Administered in Healthy Japanese Participants Compared With Matched, Healthy, Non-Hispanic, Caucasian Participants and to Assess Dose-Proportionality of 3 Doses of Maribavir in Japanese Participants

Who this might be right for
Healthy Volunteers
Shire 24
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation